Clinical Cancer Research CR Surrogrates Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gorrin-Rivas, M. J.
Right arrow Articles by Imamura, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gorrin-Rivas, M. J.
Right arrow Articles by Imamura, M.
Clinical Cancer Research Vol. 6, 1647-1654, May 2000
© 2000 American Association for Cancer Research


Advances in Brief

Mouse Macrophage Metalloelastase Gene Transfer into a Murine Melanoma Suppresses Primary Tumor Growth by Halting Angiogenesis1

Manuel J. Gorrin-Rivas2, Shigeki Arii, Masaharu Furutani, Masaki Mizumoto, Akira Mori, Koji Hanaki, Masato Maeda, Hiroaki Furuyama, Yoko Kondo and Masayuki Imamura

Department of Surgery and Surgical Basic Science [M. J. G-R., S. A., M. F., M. Mi., A. M., K. H., M. Ma., H. F., M. I.] and Division of Gastroenterology and Hepatology, Department of Internal Medicine [Y. K.], Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan

Mouse macrophage metalloelastase (MME) has been associated with the generation of angiostatin, an internal fragment of plasminogen, which inhibits angiogenesis. To clarify whether tumor cells that consistently generate MME can suppress angiogenesis and, therefore, inhibit the growth of primary tumors in vivo, we transfected a cDNA coding for MME into murine B16-BL6 melanoma cells that grow rapidly and are MME deficient. The generation of active MME in MME-transfected clones was confirmed by immunoprecipitation followed by in vitro cleavage of plasminogen. Subcutaneous implantation of these stable clones in C57BL/6 mice inhibited primary tumor growth by an average of 73% (P = 0.00002), which directly correlated with a significant reduction of blood vessel formation (~76%) in such tumors. Microangiography revealed massive angiogenesis in control tumors (mock and vector); however, in MME-transfected primary tumors it demonstrated a decreased and disrupted vascular network. Western blot analysis using a specific anti-mouse angiostatin antibody demonstrated a strong 38-kDa immunoreactive band in MME-transfected tumors and in the serum of mice bearing those tumor cells. These results show that placing MME gene directly into B16-BL6 melanoma cells is an effective approach to suppress primary tumor growth in vivo because it halts angiogenesis. Our data provide a feasible and promising strategy for gene therapy of cancer by targeting tumor vasculature.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
N. Xu, Y.-s. Wang, W.-b. Pan, B. Xiao, Y.-j. Wen, X.-c. Chen, L.-j. Chen, H.-x. Deng, J. You, B. Kan, et al.
Human {alpha}-defensin-1 inhibits growth of human lung adenocarcinoma xenograft in nude mice
Mol. Cancer Ther., June 1, 2008; 7(6): 1588 - 1597.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. M. Houghton, J. L. Grisolano, M. L. Baumann, D. K. Kobayashi, R. D. Hautamaki, L. C. Nehring, L. A. Cornelius, and S. D. Shapiro
Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases.
Cancer Res., June 15, 2006; 66(12): 6149 - 6155.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H.-S. Hofmann, G. Hansen, G. Richter, C. Taege, A. Simm, R.-E. Silber, and S. Burdach
Matrix Metalloproteinase-12 Expression Correlates with Local Recurrence and Metastatic Disease in Non-Small Cell Lung Cancer Patients
Clin. Cancer Res., February 1, 2005; 11(3): 1086 - 1092.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. W. Lee, E. Stabile, T. Kinnaird, M. Shou, J. M. Devaney, S. E. Epstein, and M. S. Burnett
Temporal patterns of gene expression after acute hindlimb ischemia in mice: insights into the genomic program for collateral vessel development
J. Am. Coll. Cardiol., February 4, 2004; 43(3): 474 - 482.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
B. K. Ambati, A. M. Joussen, J. Ambati, Y. Moromizato, C. Guha, K. Javaherian, S. Gillies, M. S. O'Reilly, and A. P. Adamis
Angiostatin Inhibits and Regresses Corneal Neovascularization
Arch Ophthalmol, August 1, 2002; 120(8): 1063 - 1068.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Koolwijk, N. Sidenius, E. Peters, C. F. M. Sier, R. Hanemaaijer, F. Blasi, and V. W. M. van Hinsbergh
Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices
Blood, May 15, 2001; 97(10): 3123 - 3131.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.